DrugDashboards

sumatriptan succinate

sumatriptan succinate · SUMATRIPTAN SUCCINATE 4 mg/.5mL · Injection · Teva Pharmaceuticals USA, Inc.

NDC 00093-2013-99 · 2400 SYRINGE in 1 BOX / .5 mL in 1 SYRINGE · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for sumatriptan succinate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $24.59 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of sumatriptan succinate (Injection)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals Inc.SUMATRIPTAN SUCCINATE 4 mg/.5mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.SUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedSUMATRIPTAN SUCCINATE 4 mg/.5mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories LimitedSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Dr. Reddys Laboratories Inc.,SUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Proficient Rx LPSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Sportpharm LLCSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.SUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.SUMATRIPTAN SUCCINATE 4 mg/.5mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.SUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "sumatriptan succinate — NDC 00093-2013-99," retrieved September 3, 2026, https://drugdashboards.com/drug/00093201399.

Free to cite with attribution — see how the data is put together.